Ahmed Samir Alfaar, Founder of Al-Moriat, shared a post on LinkedIn:
“Six years. Countless iterations. Today our work is out in the International Journal of Clinical Oncology.
We mapped the most comprehensive, nationwide picture of uveal melanoma in the U.S. (1995–2018) — covering 98–100% of the population.
What we found: incidence is stable but slightly rising; 81.3% are localized at diagnosis; 27.4% have another primary cancer (think genetics & long-term surveillance); survival in metastatic UM remains a major unmet need despite shifts to radiotherapy.
Lessons learned
• Big-data rigor beats anecdotes — harmonize registries, check assumptions, and validate trends.
• Visual analytics change minds — maps and survival curves speak across disciplines.
• Open, team-science scales impact — epidemiology + oncology + informatics = better questions and better care.
Proud of this collaboration with Dr. Mohamed H. Abdel-Rahman and Dr. Moataz Hamed Osman. With gratitude to the North American Association of Central Cancer Registries (NAACCR), the U.S. Cancer Statistics (USCS) program—CDC/NPCR and NCI/SEER—and especially the state and territorial cancer registries and tumor registrars whose meticulous work makes population-scale science possible.
If you work in ophthalmology/oncology/epi, I’d love your take and for you to share this so we can push prevention, genetics, and systemic therapy forward.”
Title: Longitudinal nationwide analysis of uveal melanoma in the United States1995–2018
Authors: Ahmad Samir Alfaar, Mohamed H. Abdel-Rahman, Moataz Hamed Osman
Read The Full Article at Springer Link.
More Posts Featuring Melanoma.
